Condition
Malignant Mesothelioma
Estimated Enrollment: 69
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: NCCTG-N0021|CDR0000068659
Study First Received: June 6, 2001
Last Updated: December 5, 2016
Estimated Primary Completion Date: August 2004
Primary Outcome Measures:
time to progression|survival|quality of life
Sponsors and Collaborators:
Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00017186
